Delivery Order SPE2DB22D2007-SPE2DB25FJ4QD
- Not listed
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $4,218.52 delivery order on July 10, 2025, for the supply of Pirfenidone 801 mg tablets (90-count units). This firm fixed price contract, which has no set-aside designation, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 and extending through December 2026. The pharmaceutical will be delivered to the company's...
- The Defense Logistics Agency awarded a $36,799.51 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Pirfenidone 267 mg capsules (270-count units) on July 25, 2025, with an ultimate completion date of July 28, 2025. This non-set-aside contract was competitively awarded and is being performed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order represents a child contract action under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 14, 2025, for the supply of Pirfenidone 267 mg capsules (270-count units) with a ceiling value of $5,487.30. This competitive, non-set-aside delivery order operates under a firm fixed price structure with an ultimate completion date of July 15, 2025. The order will be fulfilled from AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania, where the company maintains its headquarters...
- The Defense Logistics Agency awarded a delivery order valued at $58,752.17 to AmerisourceBergen Drug Corp for the supply of Pirfenidone 267 mg tablets (270-count units) with an ultimate completion date of September 3, 2025. This is a firm fixed-price, non-set-aside contract performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX...
- The Defense Logistics Agency awarded a $23,872.20 delivery order to AmerisourceBergen Drug Corp for the supply of Pirfenidone 267 mg tablets (270 count) with an ultimate completion date of August 26, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and will be performed at the company's Corporate Office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement...
- The Defense Logistics Agency awarded a $85,212.04 delivery order to AmerisourceBergen Drug Corp on June 27, 2025, for the supply of Pirfenidone 267 mg capsules (270 count). This firm fixed-price, competitively awarded contract is classified as a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The pharmaceutical will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, with a completion deadline of June 30,...
- The Defense Logistics Agency awarded a $69.4K delivery order to AmerisourceBergen Drug Corp on April 24, 2025, for the supply of Pirfenidone 267 mg capsules (270-count units). This is a firm fixed price, competitively awarded contract with no set-aside designation and a completion date of April 25, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract under AmerisourceBergen's larger Indefinite...
- This is a $1,390.65 firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 90-count tablets of the drug Pirfenidone 267 mg. The contract has a completion date of June 17, 2025 and is not set aside. Amerisourcebergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00,...
- This is a $43,130.46 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 270 count bottles of the drug Pirfenidone 267 mg tablets. The contract has an ultimate completion date of October 13, 2023. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,564,160,572 Pirfenidone 801 mg tablets in 90-count packages. The contract has a ceiling value of $2,971.38 and a period of performance through April 4, 2024. This award is a task order under a larger indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp, with a potential value of up to...
- SPE2DB22D2007Indefinite Delivery Contract
- SPE2DB22D2007-SPE2DB25FJ4QDDelivery Order
The Defense Logistics Agency awarded a $1,345.96 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 90 tablets of Pirfenidone 267 mg, with performance in Conshohocken, Pennsylvania and completion by September 5, 2025. This non-set-aside, competitively awarded contract represents a single delivery order under AmerisourceBergen's broader pharmaceutical supply relationship with DLA, fulfilling the federal government's medical procurement needs for this specialty pharmaceutical product. This delivery order is issued under AmerisourceBergen's significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs and other federal health systems worldwide. The specific delivery of Pirfenidone, a medication used in pulmonary fibrosis treatment, exemplifies the company's role as a critical vendor in the Defense Health Agency supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.3k | 9/4/25 |